Bookmark and Share
sodium 2-(1,3-benzothiazol-2-yl)-5-benzyl-4-methyl-3-oxo-3,5-dihydro-2H-pyrazolo[4,3-c]pyridin-6-olate (CID 23673720) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(54)
 
 
Inactive(388)
 
 
Inconclusive(23)
 
 
Unspecified(1)
 
 
Top Targets:
7tm 4(35)
 
 
Tryp SPc(8)
 
 
 
G-alpha(8)
 
 
 
CAP ED(4)
 
 
UBCc(4)
 
 
 
BioAssay Types:
Screening(240)
 
 
 
 
Confirmatory(207)
 
 
 
 
 
Literature(11)
 
 
BioActivity Types:
Potency(136)
 
 
 
 
 
IC50(49)
 
 
 
EC50(7)
 
 
 
AC50(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 411    Data Row: 466   Total Pages: 24   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID87544848]
IC50 1.51A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against CXCR4-tropic HIV-1 (HIV-1 PBMC Assay) - Dose Response (3) [AID504625, Type: confirmatory]
View
2
[SID87544848]
IC50 1.57A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against CCR5-tropic HIV-1 (HIV-1 PBMC Assay) - Dose Response (3) [AID504626, Type: confirmatory]
View
3
[SID87544848]
IC50 2.42A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against CCR5-tropic HIV-1 (HIV-1 PBMC Assay) - Dose Response (2) [AID504560, Type: confirmatory]
View
4
[SID26725910]
Potency 2.9362Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory]
View
5
[SID26725910]
Potency 2.9362Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory]
View
6
[SID26725910]
IC50 3.01Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory]Mint1 [Rattus norvegicus] [gi:2625023]
View
7
[SID26725910]
IC50 3.01Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory]voltage-dependent N-type calcium channel subunit alpha-1B isoform 1 [Homo sapiens] [gi:4502523]
View
8
[SID87544848]
IC50 3.21A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against CXCR4-tropic HIV-1 (HIV-1 PBMC Assay) - Dose Response (2) [AID504563, Type: confirmatory]
View
9
[SID87544848]
IC50 (2% Serum) 3.94A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CCR5-Tropic HIV-1 Fusion Inhibition Assay) - Dose Response (2) [AID504551, Type: confirmatory]
View
10
[SID26725910]
IC50 4.3226Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory]Mcl-1 [Homo sapiens] [gi:7582271]
View
11
[SID87544848]
TC50 (5% Serum) 5.4A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CCR5-Tropic HIV-1 Fusion Inhibition Assay) - Secondary Cytotoxicity Screen (2) [AID504573, Type: confirmatory]
View
12
[SID26725910]
Potency 6.3096Ub-rhodamine 110 based assay for inhibitors Ubiquitin-specific Protease USP2a [AID493170, Type: confirmatory]ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692]
View
13
[SID87544848]
IC50 6.58SAR analysis of compounds that inhibit Human Immunodeficiency Virus Fusion, cell-cell fusion assay [AID435029, Type: confirmatory]envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394]
View
14
[SID26725910]
Potency 6.7456qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory]Luciferase [Photinus pyralis] [gi:160794]
View
15
[SID87544848]
TC50 (2% Serum) 8.94A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CXCR4-Tropic HIV-1 Fusion Inhibition Assay) - Secondary Cytotoxicity Screen (2) [AID504574, Type: confirmatory]
View
16
[SID87544848]
IC50 (2% Serum) 9.28A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CCR5-Tropic HIV-1 MAGI Antiviral Assay) - Secondary Assay (4) [AID504553, Type: confirmatory]
View
17
[SID87544848]
IC50_Mean 10.1SAR analysis of compounds that inhibit Human Immunodeficiency Virus Fusion. [AID434967, Type: confirmatory]envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394]
View
18
[SID26725910]
Potency 11.2202CHOP2 Reporter Counterscreen Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID493169, Type: confirmatory]enteropeptidase precursor [Homo sapiens] [gi:223942069]
View
19
[SID87544848]
IC50 (5% Serum) 12.5A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (CCR5-Tropic HIV-1 MAGI Antiviral Assay) - Secondary Assay [AID2644, Type: confirmatory]
View
20
[SID87544848]
TC50 13.2A Cell Based Assay for the Characterization of Lead Compounds with Antiviral Activity against HIV-1 (HIV-1 PBMC Assay) - Cytotoxicity Counter Screen - Dose Response (3) [AID504630, Type: confirmatory]
View